0JXI
Madrigal Pharmaceuticals Inc.
Stock London Stock Exchange – Stock Market Prices, News & Analysis
Madrigal Pharmaceuticals Inc. est une entreprise biopharmaceutique américaine développant des traitements innovants pour les maladies cardiovasculaires et métaboliques.
Madrigal Pharmaceuticals Inc.
0JXI
Madrigal Pharmaceuticals Inc. est une entreprise biopharmaceutique américaine développant des traitements innovants pour les maladies cardiovasculaires et métaboliques.
Price history of Madrigal Pharmaceuticals Inc.
Price history of Madrigal Pharmaceuticals Inc.
Performance & Momentum
Strategic Analysis
Madrigal Pharmaceuticals Inc. • 2026
Madrigal Pharmaceuticals is a U.S. biopharmaceutical company specialized in the development of innovative treatments targeting cardiovascular and metabolic diseases. Its business model is based on advanced clinical research and a differentiated pharmacological approach in high-stakes medical niches.
- Positioning in high-growth therapeutic segments with significant unmet medical needs
- Recognized expertise in clinical research and pharmaceutical innovation
- Strong long-term value creation track record
- Exposure to regulatory risk and clinical trial outcomes
- Profitability remains uncertain given its pre-commercial stage
Recent momentum shows a renewed but moderate level of interest, with positive year-on-year performance despite short-term pressure. This trend suggests potential valued by investors as they await key clinical progress.
Similar stocks to Madrigal Pharmaceuticals Inc.
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
